Literature DB >> 11556587

Neurological manifestations in dengue patients.

C Pancharoen1, U Thisyakorn.   

Abstract

To determine the frequency and the natural history of neurological manifestations of dengue infection in Thai children, 1,493 children diagnosed with dengue infection by serology and admitted to the Department of Pediatrics, Chulalongkorn Hospital, Bangkok, Thailand from 1987 to 1998 were reviewed from prospectively recorded medical charts. There were 80 children identified with neurological manifestations, an incidence of 5.4% of all dengue patients. Of these, there were 41 males and 39 females, with ages ranging from 3 months to 14 years. They were categorized into 20 cases of dengue fever, 26 cases of dengue hemorrhagic fever and 34 cases of dengue shock syndrome. All cases experienced the neurological manifestations during the febrile stage of the illness. The patients were classified into an encephalitic group (called "dengue encephalopathy") (42), a seizure group (35) and a miscellaneous group (3). Encephalitic patients presented with alteration of consciousness (83.3%), seizure (45.2%), mental confusion (23.8%), nuchal rigidity (21.4%), spasticity of limbs (9.5%), positive clonus (4.8%), hemiplegia (2.4%) and positive kernig (2.4%), and were older than those in the other groups. Patients in the seizure group presented with seizure (100%) and positive clonus (2.9%). Abnormal laboratory findings included hyponatremia, abnormal liver enzymes and CSF pleocytosis. Dengue IgM and dengue PCR were not demonstrated in 16 CSF specimens. An autopsy finding of a child in the encephalitic group showed histologic evidence of encephalitis, the only case of confirmed dengue encephalitis in this study. One patient with encephalitic symptoms suffered from long-term neurological sequelae. The overall mortality rate was 5%. In conclusion, neurological manifestations including seizure and encephalopathy in children with dengue are not uncommon whereas dengue encephalitis is a rare entity.

Entities:  

Mesh:

Year:  2001        PMID: 11556587

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  36 in total

1.  Acute hypokalaemic quadriparesis in dengue fever.

Authors:  Amitava Roy; Anil Kumar Tripathi; Shailendra Prasad Verma; Himanshu Reddy; Nirdesh Jain
Journal:  BMJ Case Rep       Date:  2011-07-27

2.  Psychiatric manifestations as the leading symptom in an expatriate with dengue fever.

Authors:  J A Blum; S Pfeifer; C F Hatz
Journal:  Infection       Date:  2010-06-22       Impact factor: 3.553

3.  [Psychiatric manifestation of a dengue-encephalopathy].

Authors:  Hans Rittmannsberger; Christian Foff; Stefan Doppler; Robert Pichler
Journal:  Wien Klin Wochenschr       Date:  2010-10       Impact factor: 1.704

Review 4.  Neurologic aspects of infections in international travelers.

Authors:  May H Han; Joseph R Zunt
Journal:  Neurologist       Date:  2005-01       Impact factor: 1.398

Review 5.  Beyond thrombocytopaenia, haemorrhage and shock: the expanded dengue syndrome.

Authors:  Senaka Rajapakse; Milanka Wattegama; Praveen Weeratunga; P Chathurani Sigera; Sumadhya Deepika Fernando
Journal:  Pathog Glob Health       Date:  2018-12-03       Impact factor: 2.894

6.  Dengue Encephalitis in a Newborn.

Authors:  Shilpa U Kalane; Asha N Gokhale; Umesh D Kalane
Journal:  Indian J Pediatr       Date:  2021-05-20       Impact factor: 1.967

7.  NEUROLOGICAL INFECTIONS IN THE RETURNING INTERNATIONAL TRAVELER.

Authors:  May H Han; Melanie Walker; Joseph R Zunt
Journal:  Continuum (Minneap Minn)       Date:  2006-04

8.  Post dengue neurological complication.

Authors:  A H Hasliza; H Tohid; K Y Loh; P Santhi
Journal:  Malays Fam Physician       Date:  2015-08-31

Review 9.  North American encephalitic arboviruses.

Authors:  Larry E Davis; J David Beckham; Kenneth L Tyler
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

10.  Dengue: a new challenge for neurology.

Authors:  Marzia Puccioni-Sohler; Marco Orsini; Cristiane N Soares
Journal:  Neurol Int       Date:  2012-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.